The Venture Codex Logo

The Venture Codex

Sagemoore Capital

700 Canal St, 1st Floor, Stamford, CT, 06902, United States

Overview

Sagemoore Capital is a private equity firm focused on structured investments in the lower middle-market. The company utilizes an evergreen fund structure with committed capital from a small group of high net worth family office investors resulting in a patient capital base. This structure offers a flexible investment horizon designed to maximize stakeholder alignment by focusing on true long-term value creation.

Total investments
2
Lead investments
2
Investments · 12mo
0
Active investors
1

Sector focus

  • Commercial Real Estate
Visit website

Investment portfolio

  • Carie Health

    Led · Series A · Sep 2018

    Carie Health operates a HIPAA-compliant virtual care platform that lets members connect virtually with their doctor or a local U.S. board‑certified doctor 24/7. The company also provides physicians a free virtual practice platform to communicate with and enroll patients. Health systems can license Carie as a dedicated solution with administrative features such as multiple user roles and customizable marketing content. Led by founder and CEO Matt Wanderer, the company intends to use the new funding to launch a free telehealth platform. The article notes the company closed a $7m Series A round to support these efforts. No operating metrics (revenue or user counts) are provided in the article.

  • EpicMD

    Led · Series A · Dec 2017

    EpicMD offers a provider-centric telehealth technology platform and service solutions, including a free HIPAA-compliant cloud-based telemedicine product that aims to enhance physician and specialist practices. The platform is built to reduce uncompensated after-hours calls, manage prescription refill requests and lab-result communications, and provide on-demand after-hours primary care consultations. EpicMD positions itself as a mobile-first, consumer-friendly healthcare solution intended to lower costs and expand access for independent providers. The company is physician-backed and emphasizes partnerships with independent physicians and specialty practices. EpicMD plans to use new capital to accelerate national expansion and pursue related add-on acquisition opportunities. Financially, the company announced the early close of a $3 million Series A round to fund growth and M&A-related commitments.

Team